John Hancock Small Cap Fund: Reviewing Fourth Quarter Moves And Performance

The John Hancock Small Cap Core Fund outperformed its benchmark in the fourth quarter of 2025, driven by strong stock selection in industrials and...

John hancock sits at the center of this dementia and brain health question.

The John Hancock Small Cap Core Fund outperformed its benchmark in the fourth quarter of 2025, driven by strong stock selection in industrials and information technology sectors. While the broader U.S. stock market benefited from solid corporate earnings, better-than-expected economic growth, and Federal Reserve interest rate cuts, this fund’s performance came from more targeted bets within the small-cap space—particularly through holdings like Exact Sciences and MACOM Technology Solutions that captured significant gains.

This article examines the fund’s fourth quarter moves, sector positioning, capital reallocation decisions, and what the strategy tells us about where fund managers see opportunity in smaller company stocks. The John Hancock Small Cap Core Fund manages assets primarily through small-capitalization company investments, keeping at least 80 percent of net assets in companies within the Russell 2000 Index range. Understanding how and why fund managers made their Q4 moves can help investors grasp the fund’s overall direction and whether this investment approach aligns with their financial goals—especially as economic conditions shift heading into 2026.

Table of Contents

What Drove John Hancock Small Cap Fund’s Outperformance in Fourth Quarter 2025?

The fund’s outperformance in Q4 2025 stemmed directly from careful stock selection rather than simply riding broader market movements. Two holdings stood out as major contributors to returns: Exact Sciences, a leader in precision diagnostics and cancer screening, and MACOM technology Solutions, which manufactures high-performance semiconductors and RF/microwave components. These companies benefited from investor appetite for technology and healthcare innovation during a quarter marked by optimism about economic growth and moderating inflation. When fund managers identify the right small companies at the right time—companies that solve real market problems and show earnings growth—the impact on a small-cap focused fund becomes meaningful. Conversely, if managers had overweighted companies that disappointed investors or faced headwinds, the fund’s performance would have lagged its benchmark, so the Q4 results reflected solid fundamental research and timing decisions.

The broader market environment provided a tailwind, but it didn’t do the heavy lifting for this fund. The Federal Reserve’s decision to cut interest rates in Q4 2025 typically benefits small-cap stocks, which are often more sensitive to borrowing costs than large-cap companies. U.S. corporate earnings beat expectations and economic data came in stronger than anticipated, creating a favorable backdrop for equity investors overall. However, many small-cap funds and individual small-cap stocks underperformed during this same period, which is why the John Hancock fund’s ability to select winners—particularly in industrials and information technology—distinguished its results from the broader small-cap universe.

What Drove John Hancock Small Cap Fund's Outperformance in Fourth Quarter 2025?

How Is the Fund Positioned Across Sectors After Q4’s Capital Moves?

Information technology emerged as the largest sector overweight in the fund’s portfolio heading into 2026, with particular emphasis on semiconductors and enterprise security software companies. This positioning reflects a calculated bet that spending on semiconductors—driven by artificial intelligence infrastructure buildout, data center expansion, and enterprise computing upgrades—will remain robust. The overweight to industrials, which expanded as a result of fourth quarter capital reallocation, reflects expectations that manufacturing activity and capital spending could benefit from more stable interest rates and steady economic growth. However, the fund significantly reduced its healthcare sector weighting and drew down cash positions, meaning managers are committing more capital to these new bets rather than holding defensive positions.

The sector positioning carries an important caveat: when a fund overweights specific sectors, it’s making a directional call about which parts of the market will perform better. If semiconductors or industrials underperform in 2026, the fund will likely underperform its benchmark by roughly the same magnitude. Conversely, strong performance from these sectors could amplify the fund’s gains. The shift out of healthcare also means the fund is taking on more risk in a sector transition—moving away from traditionally stable healthcare stocks toward more cyclical industrials and technology names. This is a deliberate strategic move, not a mistake, but it’s the kind of position concentration that distinguishes actively managed small-cap funds from passive index funds.

John Hancock Small Cap Fund Q4 2025 Sector AllocationInformation Technology28%Industrials22%Consumer18%Healthcare15%Financials10%Source: John Hancock Investments Q4 2025 Fund Commentary

What Specific Capital Moves Did Fund Managers Make in Fourth Quarter?

During Q4 2025, the fund reallocated capital by reducing positions in healthcare stocks and cutting cash holdings, then deploying that capital into industrials and consumer sector companies. This rebalancing reflects a view among the fund’s managers that healthcare as a sector had become less attractive relative to the value available in industrial and consumer names at the end of 2025. Rather than making dramatic all-at-once changes, the fund likely executed these moves over weeks, buying into weakness and selling into strength to minimize market impact. For example, if an industrial company’s stock sold off on a minor quarterly miss, the fund may have added to its position at a better price rather than waiting for an arbitrary calendar date to rebalance.

The decision to reduce cash reflects confidence in market opportunities at higher price levels. When a fund holds significant cash, it typically means managers believe stocks are overvalued or they’re uncertain about the near-term direction. The fact that Q4 2025 saw fund managers deploying cash—the opposite move—suggests they believed the quarter presented attractive entry points for small-cap industrial and consumer companies despite valuations that had risen alongside the overall market. This is the kind of judgment call that separates active managers from passive trackers; if those managers are right, the move will boost returns in 2026 and beyond, but if they’re wrong about the relative value of these sectors, the cash reduction will work against fund performance.

What Specific Capital Moves Did Fund Managers Make in Fourth Quarter?

How Does This Fund Strategy Apply to Different Types of Investors?

The John Hancock Small Cap Core Fund operates as an actively managed small-cap equity fund, which means it suits investors with a specific profile: people seeking growth-oriented investments, those with at least a five-to-ten-year investment horizon, and individuals who believe skilled active managers can beat the market through stock selection. An investor in or near retirement might find the fund’s concentrated bets—particular sector overweights and exposure to smaller, more volatile companies—too risky for a large portion of their portfolio. Conversely, a 40-year-old with stable income and no near-term need for the capital might treat this as a core holding within a diversified portfolio, accepting the higher volatility in exchange for the fund’s growth potential. The fund’s approach also differs meaningfully from a passive small-cap index fund.

A Russell 2000 index fund would hold nearly all 2,000 companies in the small-cap universe with roughly equal weightings, whereas the John Hancock fund holds fewer positions and concentrates capital in its highest-conviction ideas. This active approach can produce outsized returns during strong years—like Q4 2025—but can also underperform during periods when the fund’s sector bets fall out of favor. If you’re comparing this fund to a passive alternative, understand that you’re paying higher fees (typically 0.8 percent to 1.2 percent for Class A shares) specifically for the active management and these stock-picking decisions. The Q4 2025 outperformance demonstrates the fund can deliver value, but there’s no guarantee the outperformance will persist, especially if the fund’s overweight sectors stumble in 2026.

What Risks Come With Small-Cap Investing and These Sector Concentrations?

Small-cap stocks inherently carry higher volatility and liquidity risk compared to large-cap companies. A company like Exact Sciences, while profitable and growing, operates in a smaller market-cap range than Apple or Microsoft, meaning its stock price can swing more dramatically on company-specific news or sector-wide sentiment shifts. The John Hancock Small Cap Core Fund’s concentrated bets on information technology and industrials amplify this risk: if semiconductor stocks fall sharply (perhaps due to oversupply concerns or spending pullbacks by major customers), the fund’s IT overweight becomes a significant drag on performance. Additionally, smaller companies have less diversified revenue streams and smaller financial cushions to survive a severe economic downturn, so a recession would likely hit this fund harder than a large-cap growth fund.

Another important consideration is that market leadership changes over time. The sectors that outperform in one quarter or year often underperform in the next. The fund’s current overweights to IT and industrials might seem well-justified after Q4 2025’s strong showing, but if consumer discretionary or healthcare leadership reasserts itself in 2026, these positions could turn into headwinds. This is precisely why investors in actively managed funds need to monitor holdings, understand the manager’s reasoning, and reassess whether the fund still aligns with their goals at least once yearly. One quarter of outperformance is encouraging but doesn’t guarantee future results, and new investors joining the fund in early 2026 would be buying after a strong quarter when valuations may be higher.

What Risks Come With Small-Cap Investing and These Sector Concentrations?

Which Share Classes and Tickers Should You Know About?

The John Hancock Small Cap Core Fund offers multiple share classes, with different investors accessing the fund through different tickers and fee structures. Class A shares trade under the ticker JCCAX and typically carry a front-end sales load (an upfront commission), though the ongoing expense ratio is competitive. Class I shares, accessed through the JCCIX ticker, typically have lower expense ratios and no front-end load but are generally restricted to institutional investors or those investing through certain platforms.

The JORSX ticker represents another class variant with its own fee structure and potential load considerations. Before investing, clarify which share class you’d actually hold and what the expense ratio and any sales charges would be, as these can meaningfully affect your long-term returns. The choice of share class matters more than many investors realize. Over a 20-year investment horizon, the difference between a 0.85 percent and a 1.15 percent annual expense ratio compounds into thousands of dollars in reduced wealth, especially in a tax-deferred account where expenses drag on returns year after year without the offset of tax-loss harvesting.

What Does Q4 2025’s Performance Signal About 2026 Positioning?

The fund’s Q4 2025 reallocation toward industrials and consumer stocks, funded by reducing healthcare and cash holdings, suggests the management team expects a resilient economic environment heading into 2026. This positioning is implicitly bullish: they’re moving capital out of cash, which generates little return, and into equities where they see opportunity. The overweight to semiconductors and IT infrastructure-related companies suggests management believes artificial intelligence spending and enterprise technology upgrades will remain a durable driver of corporate profits.

If the economy softens or corporate earnings growth stalls in 2026, this positioning could prove painful. Looking ahead, small-cap investors should monitor quarterly communications from the fund to see whether managers maintain these sector tilts or shift direction. The Q4 2025 results demonstrate that skilled active management can add value in the small-cap space, but that value depends on the team’s ability to repeatedly make correct calls about which sectors and companies will outperform. The fund’s transparency through quarterly commentary and shareholder reports gives investors visibility into these decisions, allowing you to assess whether you trust the team’s judgment before or after you invest.

Conclusion

The John Hancock Small Cap Core Fund delivered outperformance in Q4 2025 through strong stock selection, particularly in information technology and industrials, with notable contributions from holdings like Exact Sciences and MACOM Technology Solutions. The fund’s capital reallocation—reducing healthcare and cash to fund new positions in industrials and consumer sectors—reflects management confidence in the durability of growth opportunities within the small-cap universe heading into 2026.

The fund’s active management approach and sector overweights come with higher volatility and fee costs compared to passive small-cap index alternatives, but the Q4 results demonstrate that the skilled stock selection can justify those costs. If you’re evaluating whether to invest in this fund, focus on your own time horizon, risk tolerance, and whether you believe active management adds sufficient value to justify the fees. Review the fund’s quarterly commentary to understand how managers think about their bets, monitor the holdings to ensure they align with your expectations, and reassess at least annually whether the fund remains a good fit for your portfolio.


You Might Also Like

For more, see CDC — Alzheimer’s and Dementia.